Anti-PD-1 plus anti-CTLA-4 blockade overcomes immune exclusion in NSCLC brain metastases by enhancing CD8+ T cell responses and promoting tertiary lymphoid structure formation
Open Access
- 7 July 2026
- journal article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
Brain metastases (BrMs) in non-small cell lung cancer (NSCLC) respond poorly to anti-PD-1 monotherapy, but the underlying immune resistance remains incompletely defined. Here we integrate clinical outcome analyses, paired human tissue profiling and syngeneic mouse models to characterize the BrM immune microenvironment. Clinical analyses suggest improved intracranial disease control with nivolumab plus ipilimumab compared with nivolumab alone. Paired human specimens show that BrMs contain fewer cytotoxic T lymphocytes (CTLs) and tertiary lymphoid structures (TLSs) than primary tumors, defining an immune-excluded phenotype. A syngeneic BrM model recapitulates this phenotype and resists anti-PD-1 monotherapy, whereas combined anti-PD-1 and anti-CTLA-4 blockade suppresses tumor growth and prolongs survival. Single-cell RNA sequencing, flow cytometry and immunofluorescence show increased CTL infiltration and effector function after combination therapy. CD8 + T cell depletion abrogates therapeutic benefit, and combination therapy expands T follicular helper-like cells and induces TLS-like structures. These findings manifest increased adaptive immune response of dual checkpoint blockade in NSCLC BrMs.Keywords
Funding Information
- Nippon Boehringer Ingelheim Co., Ltd. JST SPRING (grant number JPMJSP2110) JSPS KAKENHI
This publication has 53 references indexed in Scilit:
- Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell CarcinomaCancer Research, 2018
- Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with NivolumabJournal of Thoracic Oncology, 2017
- Cyclic Immunofluorescence (CycIF), A Highly Multiplexed Method for Single‐cell ImagingCurrent Protocols in Chemical Biology, 2016
- Defining CD8+ T cells that provide the proliferative burst after PD-1 therapyNature, 2016
- MMEJ-assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systemsNature Protocols, 2015
- limma powers differential expression analyses for RNA-sequencing and microarray studiesNucleic Acids Research, 2015
- CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagementProceedings of the National Academy of Sciences, 2014
- Multiplex genome engineering in human cells using all-in-one CRISPR/Cas9 vector systemScientific Reports, 2014
- Chemokines and Cell Migration in Secondary Lymphoid OrgansScience, 1999
- Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete RemissionNew England Journal of Medicine, 1999